Blocking inflammation could lead to tailored medical treatments

By using a mouse model of inflammation researchers at the University of Calgary have discovered a new class of molecules that can inhibit the recruitment of some white blood cells to sites of inflammation in the body. A provisional patent has been filed on these molecules by Innovates Calgary.

Read the whole article on Physorg

More from Physorg